Multimedia support for improving preoperative patient education: a randomized controlled trial using the example of radical prostatectomy.

Application and evaluation of interactive 3D PDF for presenting and sharing planning results for liver surgery in clinical routine. PLoS One (2014) 1.51

High volume is the key for improving in-hospital outcomes after radical prostatectomy: a total population analysis in Germany from 2006 to 2013. World J Urol (2016) 0.75

Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult. BMJ (2002) 9.29

Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet (2012) 5.61

Evaluation of a general practitioner with special interest service for dermatology: randomised controlled trial. BMJ (2005) 5.56

Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension (2010) 2.38

Impact of complete bladder neck preservation on urinary continence, quality of life and surgical margins after radical prostatectomy: a randomized, controlled, single blind trial. J Urol (2012) 2.23

Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol (2010) 1.99

Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma. Clin Cancer Res (2006) 1.92

Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate. BJU Int (2013) 1.87

Variations in the hospital management of self harm in adults in England: observational study. BMJ (2004) 1.83

EAU guidelines on urological trauma. Eur Urol (2005) 1.70

Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Eur Urol (2012) 1.69

Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol (2011) 1.62

Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project). BJU Int (2013) 1.60

External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder. Eur Urol (2011) 1.56

Manual repositioning of intra-atrial kidney cancer tumor thrombus: a technique reducing the need for cardiopulmonary bypass. Urology (2013) 1.48

Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ). Eur Urol (2006) 1.43

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma. BMC Cancer (2010) 1.42

Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol (2013) 1.41

Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers. J Clin Invest (2017) 1.40

En bloc stapler ligation of the renal vascular pedicle during laparoscopic nephrectomy. BJU Int (2007) 1.39

Monolithic materials: Promises, challenges, achievements. Anal Chem (2006) 1.36

Monolithic capillary-based ion-selective electrodes. Anal Chem (2005) 1.36

A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. J Urol (2011) 1.34

Decoy receptor 3 is a prognostic factor in renal cell cancer. Neoplasia (2008) 1.33

EAU Guidelines on Urethral Trauma. Eur Urol (2010) 1.29

Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup. J Urol (2007) 1.26

Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? BJU Int (2008) 1.25

Macrophage microRNA-155 promotes cardiac hypertrophy and failure. Circulation (2013) 1.14

Two-dimensional reversed-phase x ion-pair reversed-phase HPLC: an alternative approach to high-resolution peptide separation for shotgun proteome analysis. J Proteome Res (2007) 1.13

Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod Pathol (2011) 1.11

Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial). J Clin Psychiatry (2010) 1.11

Conversion from colonic or ileal conduit to continent cutaneous urinary diversion. J Urol (2004) 1.08

Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy. BJU Int (2012) 1.08

The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells. Int J Cancer (2008) 1.08

Absolute myoglobin quantitation in serum by combining two-dimensional liquid chromatography-electrospray ionization mass spectrometry and novel data analysis algorithms. J Proteome Res (2006) 1.07

Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors. Cancer Biol Ther (2007) 1.07

Continent cutaneous urinary diversion: long-term follow-up of more than 800 patients with ileocecal reservoirs. World J Urol (2006) 1.07

Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. J Proteomics (2012) 1.06

Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Res (2008) 1.05

Statistical learning of peptide retention behavior in chromatographic separations: a new kernel-based approach for computational proteomics. BMC Bioinformatics (2007) 1.05

Adapting the randomized consent (Zelen) design for trials of behavioural interventions for chronic disease: feasibility study. J Health Serv Res Policy (2005) 1.05

Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med (2012) 1.04

Phantom study of a novel stereotactic prostate biopsy system integrating preinterventional magnetic resonance imaging and live ultrasonography fusion. J Endourol (2012) 1.02

Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome. PLoS One (2011) 1.02

Separation, detection, and identification of peptides by ion-pair reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry at high and low pH. J Chromatogr A (2005) 1.02

Depression, anxiety, and disturbed sleep in glaucoma. J Neuropsychiatry Clin Neurosci (2013) 1.00

Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol (2011) 1.00

Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy. BJU Int (2011) 0.99

Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer. Clin Cancer Res (2009) 0.98

SIMPATIQCO: a server-based software suite which facilitates monitoring the time course of LC-MS performance metrics on Orbitrap instruments. J Proteome Res (2012) 0.97

Cellular damage to human hepatocytes through repeated application of 5-aminolevulinic acid. J Hepatol (2003) 0.97

Investigating Choice Experiments for Preferences of Older People (ICEPOP): evaluative spaces in health economics. J Health Serv Res Policy (2008) 0.96

Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL. BJU Int (2008) 0.95

De novo peptide sequencing by tandem MS using complementary CID and electron transfer dissociation. Electrophoresis (2009) 0.95

Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy. Int J Radiat Oncol Biol Phys (2007) 0.95

Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' view. Urol Oncol (2012) 0.95

The centrosome as potential target for cancer therapy and prevention. Expert Opin Ther Targets (2012) 0.94

The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential. J Pineal Res (2010) 0.93

Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literature. Thyroid (2015) 0.92

Proteome analysis of Myxococcus xanthus by off-line two-dimensional chromatographic separation using monolithic poly-(styrene-divinylbenzene) columns combined with ion-trap tandem mass spectrometry. J Proteome Res (2006) 0.91

Improving peptide identification in proteome analysis by a two-dimensional retention time filtering approach. J Proteome Res (2009) 0.91

Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences. BJU Int (2008) 0.91

Comparative sequencing of nucleic acids by liquid chromatography-tandem mass spectrometry. Anal Chem (2002) 0.90

High-efficiency nano- and micro-HPLC--high-resolution Orbitrap-MS platform for top-down proteomics. Proteomics (2010) 0.90

Characterization of some physical and chromatographic properties of monolithic poly(styrene-co-divinylbenzene) columns. J Chromatogr A (2004) 0.90

Monolithic capillary columns for liquid chromatography-electrospray ionization mass spectrometry in proteomic and genomic research. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.89

High nuclear Livin expression is a favourable prognostic indicator in renal cell carcinoma. BJU Int (2008) 0.89

Decision-making in localized prostate cancer: lessons learned from an online support group. BJU Int (2010) 0.89

Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma. Scand J Urol (2012) 0.89

Prognostic variables for shockwave lithotripsy (SWL) treatment success: no impact of body mass index (BMI) using a third generation lithotripter. BJU Int (2011) 0.89

Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model. J Urol (2013) 0.88

Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol (2011) 0.88

Separate analysis of DYS385a and b versus conventional DYS385 typing: is there forensic relevance? Int J Legal Med (2004) 0.88

Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial. BJU Int (2010) 0.88

Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Curr Urol Rep (2014) 0.88

Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series. World J Urol (2012) 0.88

Prognostic stratification of localized renal cell carcinoma by tumor size. J Urol (2008) 0.88

Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas. Cancer Lett (2010) 0.87

Workflows for automated downstream data analysis and visualization in large-scale computational mass spectrometry. Proteomics (2015) 0.87

Hydrophobic, pellicular, monolithic capillary columns based on cross-linked polynorbornene for biopolymer separations. Anal Chem (2002) 0.87